Angine de Poitrine have officially launched their first U.S. tour, and there is not a ticket left to sell.
Following their U.S. concert debut at the Newport Jazz Festival in July, the anonymous Quebec microtonal duo began the tour with two sold-out nights at Denver’s Ogden Theatre on August 12 and 13. The American run stretches through December, with multiple nights added in several cities in response to demand. Every headline date is sold out.
The tour brings Khn de Poitrine and Klek de Poitrine’s increasingly difficult-to-categorize live show across the country, combining microtonal guitar, percussion, acid techno, disco, prog, noise rock and tightly constructed rhythmic patterns. The duo’s instrumental music has become particularly known for its physicality in concert, where complex time signatures and microtonal loops function less like an academic exercise and more like dance music built from an entirely different set of rules.
The itinerary includes two sold-out nights at Los Angeles’ Teragram Ballroom, an August 19 stop at The Independent in San Francisco, two September shows at New York’s Le Poisson Rouge and three November nights in Brooklyn. Later in the year, Angine de Poitrine return to California for two nights at The Wiltern in Los Angeles, followed by the Castro Theatre in San Francisco on December 7 and Oakland’s Fox Theater on December 8.
The band is also using the tour to bring a piece of Quebec’s music scene south with them. A rotating group of Quebec artists will open dates throughout the fall, including psychedelic rock band Population II, electronic singer-songwriter Annie-Claude Deschênes, noise-rock trio zouz and guitarist, composer and improviser René Lussier. JJUUJJUU and Dolphin Hyperspace are also scheduled to support select dates.
The U.S. shows are only one part of a sprawling 2026 touring schedule. Angine de Poitrine are moving between North America, Europe and the U.K., with festival appearances including Field of Vision II, KEXP BBQ, Levitation, Riot Fest and Iron Blossom Festival. Dates in Lisbon, Amsterdam, London, Paris, Berlin, Dublin and other European cities are also part of the run, many of them already sold out.
The tour follows the April release of Vol. II, the duo’s second full-length album and the latest extension of the strange musical vocabulary that has fueled their rapid rise. Built around acid techno, disco and rock, the album pushes further into microtonality and repetition, including “Fabienk,” which develops from a single microtonal guitar loop as the pattern repeats, doubles and mutates.
The June U.S. physical releases of Vol. I and Vol. II also gave Angine de Poitrine a major chart breakthrough. According to the band’s announcement, the releases debuted at No. 1 across nine Billboard charts while reaching No. 3 on Top Album Sales, No. 2 on Vinyl Albums and No. 2 on Indie Store Album Sales. The albums subsequently held the top position on the Indie Store Album chart for eight consecutive weeks.
That momentum follows a remarkable two-year ascent for a project built around anonymity, elaborate mythology and music that hardly sounds engineered for conventional crossover success. Their Live on KEXP performance has surpassed 18 million views, while the duo’s 2026 touring has included a support slot for Jack White in Toronto and a free Montreal International Jazz Festival performance reported to have drawn more than 80,000 people.
Angine de Poitrine’s U.S. festival schedule includes Riot Fest in Chicago on September 19 and Iron Blossom Festival in Richmond the following day. The headline tour resumes in November before concluding with a substantial West Coast run in December, including Los Angeles, San Francisco, Oakland, Portland and Seattle.
For a band whose music revolves around odd meters, microtones, repetition and two musicians generating a disproportionately enormous amount of sound, selling out an entire first U.S. tour suggests the weirdness is proving to be the attraction rather than the obstacle.
Featured image credit:
